Pharma Equity Group A/S (OCSE:PEG) Other Long-Term Liabilities : kr-0.00 Mil (As of Mar. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Pharma Equity Group A/S Other Long-Term Liabilities?

Pharma Equity Group A/S's other long-term liabilities for the quarter that ended in Mar. 2024 was kr-0.00 Mil.

Pharma Equity Group A/S's quarterly other long-term liabilities declined from Sep. 2023 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil) and declined from Dec. 2023 (kr0.00 Mil) to Mar. 2024 (kr-0.00 Mil).

Pharma Equity Group A/S's annual other long-term liabilities declined from Dec. 2021 (kr0.00 Mil) to Dec. 2022 (kr0.00 Mil) but then increased from Dec. 2022 (kr0.00 Mil) to Dec. 2023 (kr0.00 Mil).

Pharma Equity Group A/S Other Long-Term Liabilities Historical Data

The historical data trend for Pharma Equity Group A/S's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Equity Group A/S Other Long-Term Liabilities Chart

Pharma Equity Group A/S Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Long-Term Liabilities

Get a 7-Day Free Trial

Pharma Equity Group A/S Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Long-Term Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Pharma Equity Group A/S Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

Pharma Equity Group A/S Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group A/S's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group A/S (OCSE:PEG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Equity Group A/S (OCSE:PEG) » Definitions » Other Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Slotsmarken 18, 2.th., Horsholm, DNK, DK-2970

Website

https://www.pharmaequitygroup.com

Pharma Equity Group A/S is an investment company specializing in the life science industry. The group is focused on an early investment in various life science companies that develops technologies and therapies that have the potential to improve human health and quality of life. The group specializes in early-stage investments in biotechnology, that are developing novel therapies for unmet medical needs. Its portfolio consists of companies dedicated to developing novel, effective treatments for diseases with patient and social impact for which current therapy is lacking or in need of improvement.